chr6-52438493-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018100.4(EFHC1):āc.475C>Gā(p.Arg159Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00185 in 1,613,906 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R159Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFHC1 | NM_018100.4 | c.475C>G | p.Arg159Gly | missense_variant | 3/11 | ENST00000371068.11 | |
EFHC1 | NM_001172420.2 | c.418C>G | p.Arg140Gly | missense_variant | 4/12 | ||
EFHC1 | NR_033327.2 | n.544C>G | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFHC1 | ENST00000371068.11 | c.475C>G | p.Arg159Gly | missense_variant | 3/11 | 1 | NM_018100.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00986 AC: 1499AN: 152038Hom.: 18 Cov.: 32
GnomAD3 exomes AF: 0.00274 AC: 688AN: 251084Hom.: 7 AF XY: 0.00189 AC XY: 257AN XY: 135724
GnomAD4 exome AF: 0.00102 AC: 1489AN: 1461750Hom.: 20 Cov.: 33 AF XY: 0.000894 AC XY: 650AN XY: 727174
GnomAD4 genome AF: 0.00987 AC: 1502AN: 152156Hom.: 18 Cov.: 32 AF XY: 0.00887 AC XY: 660AN XY: 74378
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 01, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 20, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Dec 09, 2016 | - - |
EFHC1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 01, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at